New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

273 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-16

Study Completion Date

2022-09-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial studies how well new magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) software works in improving the image quality of scans in both patients and healthy volunteers. Improving the image quality of MRI and MRSI through new software may lead to implementation of these techniques and better clinical care for patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors

NCT00507884

Kidney Neoplasms

UNKNOWN

Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma

NCT00072488

Lymphoma Neuroblastoma Sarcoma

UNKNOWN NA

Comparison of 18F FDG PET/CT TO PET MRI

NCT01986985

Any Condition With a Clinical Indication for PET/CT Exam

COMPLETED NA

Pediatric PET/MR Image Registry

NCT03458520

Soft Tissue Lymphoma Osteosarcoma

RECRUITING

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

NCT00019565

Unspecified Adult Solid Tumor, Protocol Specific

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. To help develop and/or optimize new magnetic resonance (MR) imaging and spectroscopy applications and analysis software in order to provide the best MR services for our patients.

OUTLINE:

Patients undergo an additional investigational MRI or MRSI sequence along with the standard MRI or MRSI. Healthy volunteers undergo an investigational MRI or MRSI sequence. Healthy volunteers may also undergo an additional standard sequence if there is one that can be compared to the investigational sequence. All MRI or MRSI procedures, including the standard MRI or MRSI, are no longer than 60 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Device Feasibility (MRI, MRSI)

Patients undergo an additional investigational MRI or MRSI sequence along with the standard MRI or MRSI. Healthy volunteers undergo an investigational MRI or MRSI sequence. Healthy volunteers may also undergo an additional standard sequence if there is one that can be compared to the investigational sequence. All MRI or MRSI procedures, including the standard MRI or MRSI, are no longer than 60 minutes.

Group Type EXPERIMENTAL

Magnetic Resonance Imaging

Intervention Type PROCEDURE

Undergo MRI

Magnetic Resonance Spectroscopic Imaging

Intervention Type PROCEDURE

Undergo MRSI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic Resonance Imaging

Undergo MRI

Intervention Type PROCEDURE

Magnetic Resonance Spectroscopic Imaging

Undergo MRSI

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Magnetic Resonance Imaging Scan Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance MR Imaging MRI MRI Scan NMR Imaging NMRI Nuclear Magnetic Resonance Imaging 1H- Nuclear Magnetic Resonance Spectroscopic Imaging 1H-nuclear magnetic resonance spectroscopic imaging Magnetic Resonance Spectroscopy MRS MRS Imaging MRSI Proton Magnetic Resonance Spectroscopic Imaging

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are scheduled for routine MR imaging or spectroscopy examinations at MD Anderson Cancer Center (MDACC).
* Written informed consent will be obtained from each subject scanned who enrolled to individual sub-project under this protocol.
* HEALTHY VOLUNTEERS: Written informed consent will be obtained from each subject scanned who enrolled to individual sub-project under this protocol

Exclusion Criteria

* No pregnant subjects will be enrolled
* No one under 18 years of age will be enrolled
* No investigational devices or drugs will be used.
* No contraindications to MR exam(s)
* HEALTHY VOLUNTEERS: No pregnant subjects will be enrolled
* HEALTHY VOLUNTEERS: No one under 18 years of age will be enrolled
* HEALTHY VOLUNTEERS: No investigational devices or drugs will be used
* HEALTHY VOLUNTEERS: No contraindications to MR exam(s) - healthy volunteers will use the same screening process utilized for MDACC patients (DI Patient Record - Part I, MR Screening Section)
* HEALTHY VOLUNTEERS: Healthy volunteers (including healthy MD Anderson employee volunteers) under the direct report of a sub-project principal investigator (PI) will be excluded for that specific sub-project.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes